← Open Payments lookup

KRISTI CATACUTAN: Open Payments

NPI 1780239210 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,186 in 63 payments from 19 companies in 2025. Trend: 2023 $87 · 2024 $123 · 2025 $1,186

Food & beverage: $1,186
CompanyPaymentsAmount
GlaxoSmithKline, LLC.11$178
AstraZeneca Pharmaceuticals LP10$152
Bayer Healthcare Pharmaceuticals Inc.7$136
Boehringer Ingelheim Pharmaceuticals, Inc.6$135
Novo Nordisk Inc5$113
Lilly USA, LLC3$62
Exact Sciences Corporation3$58
Axsome Therapeutics, Inc.2$50
ABBVIE INC.3$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40

Products named: JARDIANCE, Kerendia, TRELEGY ELLIPTA, Ozempic, AIRSUPRA, BREZTRI, FARXIGA, Rybelsus.

Industry payments across TX — which companies pay providers there.